The good news about this vaccine-research sea change for people already infected is that many new candidates show promise as treatments, too. Here’s why: The type of anti-HIV T-cell immune response that they aim for is likely also critical for controlling HIV infection. Once HAART suppresses viral replication, your body is freed up to make new T-cells -- cells that a vaccine then could whip into a bigger, better immune response. The goal of this HAART/vax duo is ultimately to stop the meds and let your body take over the control of enemy HIV. For more about this revolutionary approach see “Sleeping With the Enemy.”